Collectively, these studies suggest that frequent EBV reactivation may exacerbate SLE disease activity by promoting IFN-associated inflammatory responses directly or indirectly through the generation of autoantibodies and impaired apoptotic clearance. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.